We focus on autoimmune disease sub-fields, providing targeted preclinical research solutions for new drug R&D, covering model construction, efficacy evaluation and IND application support for various autoimmune diseases.
We collaborate with innovative pharmaceutical companies worldwide to tackle the challenges of treating autoimmune diseases. Recognition from our partners is our greatest motivation.
Before working with HKeyBio, we had reservations about outsourcing preclinical studies for a complex autoimmune project overseas. Their professional NHP model data, deep understanding of FDA filing requirements, and seamless communication completely addressed our concerns. The quality of their data was a key factor in our project’s successful IND approval in the US.
We evaluated several CROs specializing in autoimmunity. HKeyBio’s depth and scientific rigor in disease models, particularly non-human primate models, were impressive. They are not just a service provider but a trusted scientific partner.
When selecting HKeyBio as the preclinical partner for a key autoimmune program, we valued not only their internationally compliant NHP model data but, more importantly, the deep disease biology insights and exceptional execution efficiency demonstrated by their team. They effectively translate the advantages of China‘s R&D ecosystem into tangible ‘time and cost efficiencies’ for our project, proving to be a trusted strategic R&D partner.